Datwyler considering China medical-parts foray

Altdorf, Switzerland – Datwyler is currently evaluating entry into the Chinese healthcare market via “acquisition or a greenfield approach,” according to a company spokesman.

A particular focus is on components for injectable drugs, which are currently imported into China, Datwyler head corporate communication Guido Unternaehrer said in a 20 Nov written statement to ERJ.

The Swiss company’s spokesman declined to comment further on the plans for China but pointed out that Datwyler’s healthcare business is undergoing a phase of global-expansion.

Recent investments include an upgrade to the company’s…

To read more,please login or register below.

Register
This is the first step to more free
content, user offers, subscriptions
and more.
Login
Log in here using the Email Address
and Password you signed up with